Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk males

Vaccine

Volumn 27, Issue SUPPL. 1, 2009, Pages

  Orlando, Giovanna ^a   Beretta, Rosangela ^a   Fasolo, M Michela ^a   Amendola, Antonella ^b   Bianchi, Silvia ^b   Mazza, Francesca ^a   Rizzardini, Giuliano ^a   Tanzi, Elisabetta ^b  

^a Department of Infectious Diseases   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Anal intraepithelial neoplasia; Geographical HPV distribution; HPV genotypes

Indexed keywords

ADULT; ANUS CANCER; ANUS DISEASE; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CYTOLOGY; DISEASE COURSE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 13; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 30; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 32; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 34; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 57; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 72; HUMAN PAPILLOMAVIRUS TYPE 84; HUMAN PAPILLOMAVIRUS TYPE C62; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRECANCER; PRIORITY JOURNAL; PROBABILITY; RANK SUM TEST; RISK ASSESSMENT; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL; TIME SERIES ANALYSIS; VERRUCA VULGARIS; WART VIRUS;

ADULT; ANAL CANAL; ANUS NEOPLASMS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; GENOTYPE; HIV INFECTIONS; HUMANS; ITALY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 66049114964     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.026     Document Type: Article

References (31)

1. Chiao E.Y., Krown S.E., Stier E.A., and Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immun Defic Syndr 40 4 (2005) 451-455
2. Bower M., Powles T., Newsom-Davis T., Thirlwell C., Stebbing J., Mandalia S., et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?. J Acquir Immun Defic Syndr 37 (2004) 1563-1565
3. Baldwin S.B., Wallace D.R., Papenfuss M.R., Abrahamsen M., Vaught L.C., Kornegay J.R., et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 187 (2003) 1064-1070
4. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., and Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 194 (2006) 1044-1057
5. Fox P.A. Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 19 (2006) 62-66
6. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., and Daling J.R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101 (2004) 281-288
7. MMWR Quadrivalent Human Papillomavirus Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007;56 (RR02):1-24.
8. Schiffman M., and Kjaer S.K. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31 (2003) 14-19
9. Munoz N., Bosch F.X., de SanJose S., Herrera R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus type associated with cervical cancer. N Engl J Med 348 (2003) 518-527
10. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and Hausena H. Classification of papillomaviruses. Virology 324 (2004) 17-27
11. Trottie H., and Franco L. The epidemiology of genital human papillomavirus infection. Vaccine 24S1 (2006) S1/4-S/10
12. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J.F., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
13. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
14. Manos M.M., Ting Y., Wright D.K., et al. The use of polymerase chain reaction amplifications for the detection of genital human papillomaviruses. Cancer Cell 7 (1989) 209-214
15. Puranen M., Saarikoski S., Syrjänen K., and Syrjänen S. Polymerase chain reaction amplification of human papillomavirus DNA from archival. Papanicolaou-stained cervical smears. Acta Cytol. 40 3 (1996) 391-395
16. Bernad H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., et al. Identification and assessment of know and novel human papillomavirus by polymarase chain reaction amplification, restriction fragment legth polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170 (1994) 1077-1085
17. Piketty C., Darragh T.M., Da Costa M., Bruneval P., Heard I., Kazatchkine M.D., et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Int Med 138 (2003) 453-459
18. Wilkin T.J., Palmer S., Brudney K.F., Chiasson M.A., and Wright T.C. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190 (2004) 1685-1691
19. Castellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98 5 (2006) 303-315
20. Laytragoon-Lewin N., Nilsson P.J., Castro J., Gharizadeh B., Nyren P., Glimelius B., et al. Human papillomavirus (HPV). DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients. Anticancer Res 27 6C (2007) 4473-4479
21. Goldie S.J., Kuntz K.M., Weinstein M.C., Freedberg K.A., and Palefsky J.M. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 108 (2000) 634-641
22. Scott H., Khoury J., Moore B.A., and Weissman S. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 35 2 (2008) 197-202
23. Orlando G., Tanzi E., Beretta R., Amendola A., Fasolo M.M., Bianchi S., et al. Human papillomavirus genotypes and anal-related lesions among HIV-1-infected men in Milan, Italy. JAIDS 47 (2008) 129-131
24. Xi L.F., Carter J.J., Galloway D.A., Kuypers J., Hughes J.P., Lee S.K., et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11 (2002) 343-351
25. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81 (2000) 2959-2968
26. Pista A., Oliveira A., Barateiro A., Costa H., Verdasca N., and Paixão M.T. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol 79 12 (2007) 1889-1897
27. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120 8 (2007) 1763-1768
28. Aho J., Hankins C., Tremblay C., Forest P., Pourreaux K., Rouah F., et al. Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. J Infect Dis 190 (2004) 46-52
29. Chan P.K., Lam C.W., Cheung T.H., Li W.W., Lo K.W., Chan M.Y., et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94 (2002) 1249-1253
30. Cheung J.L., Cheung T.H., Tang J.W., and Chan P.K. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer. J Clin Microbiol 46 4 (2008) 1356-1362
31. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14 5 (2005) 1157-1164